• / Free eNewsletters & Magazine
  • / My Account
Home>Ocular Therapeutix Announces Second Quarter 2014 Financial Results

Ocular Therapeutix Announces Second Quarter 2014 Financial Results

3party Content

Fri, 29 Aug 2014

Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the second quarter ended June 30, 2014. “The past several months have been
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.